Category archives for: Industry News

Humana to focus on Medicare Part D and Medicare Advantage patients in 2017

The insurer celebrates a healthy fiscal year by doubling down on Medicare Advantage and Medicare Part D.

Health Republic posts losses of $500M in 2015

Health Republic Insurance of New York lost $500 million from operations in 2015, the year it shut down after state and federal regulators said it was headed toward insolvency.

Codeine and Tramadol Can Cause Breathing Problems for Children

The FDA is strengthening drug labels for codeine and tramadol to protect children and nursing babies.

MDLive sued over patient privacy concerns

MDLive has been hit with a class-action lawsuit accusing the telehealth provider of violating patients’ privacy rights and sharing confidential information with third-party contractors.

FDA Approves Genentech’s Lucentis (ranibizumab) for all Forms of Diabetic Retinopathy

South San Francisco, CA — April 17, 2017 — Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug Administration (FDA) approved Lucentis® (ranibizumab injection) 0.3 mg for the monthly…

Theranos agrees to pay $4.65 million in Arizona refunds

Embattled blood testing company Theranos, Inc. has agreed to pay $4.65 million to cover full refunds for every Arizona customer who used the company’s testing services, Arizona Attorney General Mark Brnovich announced Tuesday.

The FDA Supports Research to Reduce Health Disparities

Scientific researchers now are working on how to reduce health disparities (differences in health outcomes) among racial and ethnic minorities. And they’re doing it with the help of funding from–and by working with–the U.S. Food and Drug Administration. Learn more.

CMS to evaluate Montana's Medicaid expansion

The CMS will evaluate Montana’s Medicaid expansion program despite senior Trump administration officials’ opposition to similar audits in the past.

Silver Cross taps chief strategy officer as new CEO

Silver Cross Hospital, one of the few independent hospitals left in the Chicago…

FDA user fee extension poised to benefit healthcare companies

The tentative deal to reauthorize the FDA’s ability to collect user fees could be a boon to many healthcare companies by providing more certainty and efficiency in the product approval process, healthcare and legal experts said.

Pharmaceutical Stocks

[stock-ticker]

© 2017 Drugs News All rights reserved.       Privacy Policy       Contact Us